Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4215111
Max Phase: Preclinical
Molecular Formula: C41H34N2O6S2
Molecular Weight: 714.87
Molecule Type: Small molecule
Associated Items:
ID: ALA4215111
Max Phase: Preclinical
Molecular Formula: C41H34N2O6S2
Molecular Weight: 714.87
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COC(=O)[C@H]1C[C@@H](S(=O)(=O)c2ccccc2)C(c2ccccc2)(c2ccccc2)N1c1nc(-c2ccccc2)c(C(=O)c2ccc(OC)cc2)s1
Standard InChI: InChI=1S/C41H34N2O6S2/c1-48-32-25-23-29(24-26-32)37(44)38-36(28-15-7-3-8-16-28)42-40(50-38)43-34(39(45)49-2)27-35(51(46,47)33-21-13-6-14-22-33)41(43,30-17-9-4-10-18-30)31-19-11-5-12-20-31/h3-26,34-35H,27H2,1-2H3/t34-,35-/m1/s1
Standard InChI Key: XKCYUUGJYZEYSY-VSJLXWSYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 714.87 | Molecular Weight (Monoisotopic): 714.1858 | AlogP: 7.59 | #Rotatable Bonds: 10 |
Polar Surface Area: 102.87 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 8.92 | CX LogD: 8.92 |
Aromatic Rings: 6 | Heavy Atoms: 51 | QED Weighted: 0.11 | Np Likeness Score: -0.62 |
1. Nural Y, Gemili M, Ulger M, Sari H, De Coen LM, Sahin E.. (2018) Synthesis, antimicrobial activity and acid dissociation constants of methyl 5,5-diphenyl-1-(thiazol-2-yl)pyrrolidine-2-carboxylate derivatives., 28 (5): [PMID:29433925] [10.1016/j.bmcl.2018.01.045] |
Source(1):